Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma

NCT03710603

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Alfred Hospital Melbourne, Australia
  • University Hospital Leuven Leuven, Belgium
  • University Hospital Ostrava Ostrava, Czechia
  • Odense University Hospital Odense, Denmark
View all 13 locations
View Trial Details
Active, Not Recruiting

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

NCT04850846

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Dana-Farber at Brighton Brighton, Massachusetts, United States
  • Dana-Farber at Merrimack Valley Methuen, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma

NCT03933735

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of California San Francisco (UCSF) - Parnassus Heights /ID# 238680 San Francisco, California, United States
  • Tulane University School of Medicine /ID# 242322 New Orleans, Louisiana, United States
  • Mayo Clinic - Rochester /ID# 238683 Rochester, Minnesota, United States
  • Washington University-School of Medicine /ID# 238681 St Louis, Missouri, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

NCT06097364

Conditions
Disease Attributes, Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, +12 more
Locations
  • Boca Raton Clinical Research (BRCR) Global Plantation, Florida, United States
  • Investigative Clinical Research of Indiana Noblesville, Indiana, United States
  • Cancer Center of Kansas Wichita, Kansas, United States
  • University of Kentucky Lexington, Kentucky, United States
View all 145 locations
View Trial Details

Related conditions